Liya Ding
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Immunology top 10%
- interferon and immune responses
Papers in
-
- Epigenetics and DNA Methylation 3
- RNA modifications and cancer 3
- Oncology 8
- PARP inhibition in cancer therapy 5
- Co-authors
- Haojie Huang (7 shared papers)Qiwei Wang (5 shared papers)Ursula A. Matulonis (5 shared papers)Hye‐Jung Kim (4 shared papers)Panagiotis A. Konstantinopoulos (5 shared papers)Shaozhen Xie (3 shared papers)Thomas M. Roberts (4 shared papers)Jean J. Zhao (4 shared papers)
- Journals
- The EMBO Journal (2 papers)Oncotarget (2 papers)Cancer Research (2 papers)Clinical Cancer Research (1 paper)Journal of Bacteriology (1 paper)
- Partner nations
- United StatesChinaFinland
In The Last Decade
Liya Ding
21 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Cancer Research 342
- Immunology 394
- Oncology 468
- Molecular Biology 831
- Reproductive Medicine 80
Countries citing papers authored by Liya Ding
This map shows the geographic impact of Liya Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liya Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liya Ding more than expected).
Fields of papers citing papers by Liya Ding
This network shows the impact of papers produced by Liya Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liya Ding. The network helps show where Liya Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Liya Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer Hit paper breakdown → | 2018 | 395 |
| 2 | STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer Hit paper breakdown → | 2022 | 163 |
| 3 | 2015 | 152 | |
| 4 | 2013 | 92 | |
| 5 | 2014 | 80 | |
| 6 | 2023 | 62 | |
| 7 | 2019 | 60 | |
| 8 | 2014 | 59 | |
| 9 | 2010 | 58 | |
| 10 | 2015 | 42 | |
| 11 | 1990 | 38 | |
| 12 | 2014 | 35 | |
| 13 | CBP loss cooperates with PTEN haploinsufficiency to drive prostate cancer: implications for epigenetic therapy | 2014 | 28 |
| 14 | 1994 | 25 | |
| 15 | 2006 | 17 | |
| 16 | 2015 | 6 | |
| 17 | 2013 | 3 | |
| 18 | 2022 | 3 | |
| 19 | 2024 | 2 | |
| 20 | 2019 | 2 |
About Liya Ding
Liya Ding is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 21 papers that have together received 1.3k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (5 papers), Epigenetics and DNA Methylation (3 papers), interferon and immune responses (3 papers), Prostate Cancer Treatment and Research (3 papers), RNA modifications and cancer (3 papers), Ovarian cancer diagnosis and treatment (2 papers), Cancer-related molecular mechanisms research (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Cancer Research (342 citations), Immunology (394 citations), Oncology (468 citations), Molecular Biology (831 citations) and Reproductive Medicine (80 citations). Liya Ding has collaborated with scholars based in United States, China and Finland. Frequent co-authors include Haojie Huang, Qiwei Wang, Ursula A. Matulonis, Hye‐Jung Kim, Panagiotis A. Konstantinopoulos, Shaozhen Xie, Thomas M. Roberts, Jean J. Zhao, Liguo Wang and R. Jeffrey Karnes. Their work appears in journals such as The EMBO Journal, Oncotarget, Cancer Research, Clinical Cancer Research and Journal of Bacteriology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.